Evaluation of a multimodal ctDNA-based assay for detection of aggressive cancers lacking standard screening tests

  • Version
  • Download 7
  • File Size 1.19 MB
  • File Count 1
  • Create Date October 29, 2024
  • Last Updated November 5, 2024

We identified numerous shared ctDNA signals across five common cancers and LSS cancers, demonstrating that SPOT-MAS could serve as a non-invasive method for detecting low-prevalence cancers with 96.2% specificity and 74.8% overall sensitivity, including a sensitivity of 60.7% for early-stage detection.


Download

SPOT-MAS Videos

Play Video
Play Video
Play Video

Test Process

01

Request the test

Request the test through your primary care doctor. A prescription and 10ml blood collection are required.

02

Sequencing of cfDNA

Your extracted DNA from the plasma will be sequenced by Next–generation ctDNA technology to analyze methylation profile and multi–feature of DNA.

03

Returning results

Receive your ctDNA signal analysis results after 20 working days from the time sample is received at Gene Solutions Genomics Singapore laboratory.

SPOT-MAS video